You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Evidence
Like S:∆S31, T22N adds a glycan in the N1 NTD loop. The reference-genome residue numbers make these glycans seem far apart (S:22 and S:30), but the S:24-26 deletion in all BA.2 means these glycans are only separated by 5 AA. The distinct growth advantage of S:∆S31 suggests that S:T22N might convey an advantage as well. Recent collection dates and sequences in two very distant regions of the world (SE Asia and Canada) make this one worth monitoring.
Usher fails to register S:T22N for the majority of the sequences here, presumably because so many labs are still unable to register either BA.2.86's MPLF insertion or BA.2's S:∆24-26.
Description
Sub-lineage of: KS.1 (JN.1.13.1.1) = JN.1 + S:F59S, S:R346T, S:F456L, S:A1087S
Earliest sequence: 2024-4-15, Singapore
Most recent sequence: 2024-5-8, Taiwan
Continents circulating: Asia (7), North America (5)
Countries circulating: Singapore (6), Canada (5), Taiwan (1)
Number of Sequences: 12
GISAID Nucleotide Query: C19716T, C21627A, T21738C
CovSpectrum Query: Nextcladepangolineage: JN.1.13* & [2-of: T21738C, C21627A]
Substitutions on top of X:
Spike: T22N (adds glycan)
Nucleotide: C19716T, C21627A
Phylogenetic Order of Mutations: C19716T & C21627A (S:T22N) both gained on same branch (as it now appears)
USHER Tree
![image](https://private-user-images.githubusercontent.com/33738461/331722839-4978736f-eb47-4317-b339-898637a836a0.png?jwt=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.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.bQZNEy0e3aHZunDb1V_gbPATizpYXLrwwKP3pbgyqp8)
https://nextstrain.org/fetch/raw.githubusercontent.com/ryhisner/jsons2/main/KS.1_T22N.json?branchLabel=nuc%20mutations&c=gt-nuc_19716&gmax=20716&gmin=18716&label=id:node_7127001
Evidence
Like S:∆S31, T22N adds a glycan in the N1 NTD loop. The reference-genome residue numbers make these glycans seem far apart (S:22 and S:30), but the S:24-26 deletion in all BA.2 means these glycans are only separated by 5 AA. The distinct growth advantage of S:∆S31 suggests that S:T22N might convey an advantage as well. Recent collection dates and sequences in two very distant regions of the world (SE Asia and Canada) make this one worth monitoring.
Usher fails to register S:T22N for the majority of the sequences here, presumably because so many labs are still unable to register either BA.2.86's MPLF insertion or BA.2's S:∆24-26.
Genomes
Genomes
EPI_ISL_19095650, EPI_ISL_19095653, EPI_ISL_19095801, EPI_ISL_19095899, EPI_ISL_19095929, EPI_ISL_19096025, EPI_ISL_19100317, EPI_ISL_19119032, EPI_ISL_19119211, EPI_ISL_19119226, EPI_ISL_19130961, EPI_ISL_19134178The text was updated successfully, but these errors were encountered: